Concepedia

Steffan Ekman

SE

Statistics

Publications

10

Citations

4.2K

H-Index

10

Active since

1994

Affiliations

Novartis (Switzerland)(Current)

Ospedale Maggiore

State University of New York

University of Gothenburg

University of Michigan

Steffan Ekman is an author at Novartis (Switzerland) specializing in medicine, clinical pharmacology, and thromboembolism prevention.

Publications per year

1994–2006

10

Publications

10

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

Stevo Julius, Sverre E. Kjeldsen, Michael A. Weber et al. · The Lancet · 2004 · 2.5K citations

, , +13

Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial

Michael A. Weber, Stevo Julius, Sverre E. Kjeldsen et al. · The Lancet · 2004 · 592 citations

, , +11

A Comparison of Recombinant Hirudin with a Low-Molecular-Weight Heparin to Prevent Thromboembolic Complications after Total Hip Replacement

Bengt I. Eriksson, Peter Kälebo, Patrick Mouret et al. · New England Journal of Medicine · 1997 · 371 citations · Full text

, , +17

Prevention of deep-vein thrombosis after total hip replacement: direct thrombin inhibition with recombinant hirudin, CGP 39393

Bengt I. Eriksson, P Kälebo, B Zachrisson et al. · The Lancet · 1996 · 176 citations

, , +16

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial

Sverre E. Kjeldsen, Stevo Julius, Giuseppe Mancia et al. · Journal of Hypertension · 2006 · 163 citations

, , +17

1–5 of 10